| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |